Arca Biopharma | ABIO - Equity Capital And Reserves


Arca Biopharma reported $486.79M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Amgen USD 8.66B 961M Dec/2025
Arca Biopharma USD 486.79M 143.15M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Brainstorm Cell Therapeutics USD -7.69M 1.64M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Capricor Therapeutics USD 83.87M 21.11M Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
CSL USD 18.66B 2.75B Dec/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Daiichi Sankyo JPY 1.71T 57.86B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025
Laboratory Of America USD 8.62B 93.2M Dec/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Otsuka Holdings JPY 3.03T 174.32B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
United Therapeutics USD 7.1B 506M Dec/2025